Literature DB >> 28057861

Cellular context-dependent consequences of Apc mutations on gene regulation and cellular behavior.

Kyoichi Hashimoto1,2, Yosuke Yamada1,3, Katsunori Semi1,4, Masaki Yagi1, Akito Tanaka1, Fumiaki Itakura1, Hitomi Aoki5, Takahiro Kunisada5, Knut Woltjen1,6, Hironori Haga3, Yoshiharu Sakai2, Takuya Yamamoto1,4,7, Yasuhiro Yamada8,4.   

Abstract

The spectrum of genetic mutations differs among cancers in different organs, implying a cellular context-dependent effect for genetic aberrations. However, the extent to which the cellular context affects the consequences of oncogenic mutations remains to be fully elucidated. We reprogrammed colon tumor cells in an ApcMin/+ (adenomatous polyposis coli) mouse model, in which the loss of the Apc gene plays a critical role in tumor development and subsequently, established reprogrammed tumor cells (RTCs) that exhibit pluripotent stem cell (PSC)-like signatures of gene expression. We show that the majority of the genes in RTCs that were affected by Apc mutations did not overlap with the genes affected in the intestine. RTCs lacked pluripotency but exhibited an increased expression of Cdx2 and a differentiation propensity that was biased toward the trophectoderm cell lineage. Genetic rescue of the mutated Apc allele conferred pluripotency on RTCs and enabled their differentiation into various cell types in vivo. The redisruption of Apc in RTC-derived differentiated cells resulted in neoplastic growth that was exclusive to the intestine, but the majority of the intestinal lesions remained as pretumoral microadenomas. These results highlight the significant influence of cellular context on gene regulation, cellular plasticity, and cellular behavior in response to the loss of the Apc function. Our results also imply that the transition from microadenomas to macroscopic tumors is reprogrammable, which underscores the importance of epigenetic regulation on tumor promotion.

Entities:  

Keywords:  cancer epigenetics; colon cancer; iPS cell; mouse model; plasticity

Mesh:

Year:  2017        PMID: 28057861      PMCID: PMC5278462          DOI: 10.1073/pnas.1614197114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

2.  Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis.

Authors:  Yasuhiro Yamada; Laurie Jackson-Grusby; Heinz Linhart; Alex Meissner; Amir Eden; Haijiang Lin; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-08       Impact factor: 11.205

3.  Localization of the gene for familial adenomatous polyposis on chromosome 5.

Authors:  W F Bodmer; C J Bailey; J Bodmer; H J Bussey; A Ellis; P Gorman; F C Lucibello; V A Murday; S H Rider; P Scambler
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

4.  Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.

Authors:  V Korinek; N Barker; P J Morin; D van Wichen; R de Weger; K W Kinzler; B Vogelstein; H Clevers
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

5.  Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling.

Authors:  Menno F Kielman; Maaret Rindapää; Claudia Gaspar; Nicole van Poppel; Cor Breukel; Sandra van Leeuwen; Makoto Mark Taketo; Scott Roberts; Ron Smits; Riccardo Fodde
Journal:  Nat Genet       Date:  2002-11-11       Impact factor: 38.330

6.  The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development.

Authors:  C Bonhomme; I Duluc; E Martin; K Chawengsaksophak; M-P Chenard; M Kedinger; F Beck; J-N Freund; C Domon-Dell
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

7.  Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene.

Authors:  L K Su; K W Kinzler; B Vogelstein; A C Preisinger; A R Moser; C Luongo; K A Gould; W F Dove
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

8.  Nuclear cloning of embryonal carcinoma cells.

Authors:  Robert H Blelloch; Konrad Hochedlinger; Yasuhiro Yamada; Cameron Brennan; Minjung Kim; Beatrice Mintz; Lynda Chin; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

9.  Identification of stem cells in small intestine and colon by marker gene Lgr5.

Authors:  Nick Barker; Johan H van Es; Jeroen Kuipers; Pekka Kujala; Maaike van den Born; Miranda Cozijnsen; Andrea Haegebarth; Jeroen Korving; Harry Begthel; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

10.  Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.

Authors:  Lukas E Dow; Kevin P O'Rourke; Janelle Simon; Darjus F Tschaharganeh; Johan H van Es; Hans Clevers; Scott W Lowe
Journal:  Cell       Date:  2015-06-18       Impact factor: 41.582

View more
  11 in total

Review 1.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

2.  Molecular Pathogenesis and Classification of Colorectal Carcinoma.

Authors:  Anup Kasi; Shivani Handa; Sajjad Bhatti; Shahid Umar; Ajay Bansal; Weijing Sun
Journal:  Curr Colorectal Cancer Rep       Date:  2020-08-15

Review 3.  The causal relationship between epigenetic abnormality and cancer development: in vivo reprogramming and its future application.

Authors:  Yosuke Yamada; Yasuhiro Yamada
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2018       Impact factor: 3.493

Review 4.  Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology.

Authors:  Yuko Sogabe; Hiroshi Seno; Takuya Yamamoto; Yasuhiro Yamada
Journal:  Cancer Sci       Date:  2018-08-15       Impact factor: 6.716

Review 5.  Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells.

Authors:  Huensuk Kim; Christoph Schaniel
Journal:  Front Immunol       Date:  2018-09-28       Impact factor: 7.561

Review 6.  Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex.

Authors:  Youn-Sang Jung; Jae-Il Park
Journal:  Exp Mol Med       Date:  2020-02-10       Impact factor: 8.718

7.  Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells.

Authors:  Yusuke Azami; Naohiro Tsuyama; Yu Abe; Misaki Sugai-Takahashi; Ken-Ichi Kudo; Akinobu Ota; Karnan Sivasundaram; Moe Muramatsu; Tomonari Shigemura; Megumi Sasatani; Yuko Hashimoto; Shigehira Saji; Kenji Kamiya; Ichiro Hanamura; Takayuki Ikezoe; Masafumi Onodera; Akira Sakai
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

8.  Bringing Induced Pluripotent Stem Cell Technology to the Bedside.

Authors:  Peter Karagiannis; Ayaka Nakauchi; Shinya Yamanaka
Journal:  JMA J       Date:  2018-09-28

9.  The miR-106b/NR2F2-AS1/PLEKHO2 Axis Regulates Migration and Invasion of Colorectal Cancer through the MAPK Pathway.

Authors:  Shuzhen Liu; Guoyan An; Qing Cao; Tong Li; Xinyu Jia; Lei Lei
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

Review 10.  Multifaceted Interpretation of Colon Cancer Stem Cells.

Authors:  Yuichiro Hatano; Shinya Fukuda; Kenji Hisamatsu; Akihiro Hirata; Akira Hara; Hiroyuki Tomita
Journal:  Int J Mol Sci       Date:  2017-07-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.